Clinical trial Recruiting at 6 sites Interventional Ages 12 to 25

Program to help youths at high risk for psychosis in Sacramento

Official title: Increasing Access to Evidence-Based CHR-P Assessment and Treatment Via Stepped-Care in Community-based Settings

Run by University of California, Davis · NCT06640803 · Data updated 2026-11-12

This study is testing a new program to help young people in Sacramento who are at risk for psychosis by providing them with better support and treatment options in local mental health clinics.

More Clinical High Risk for Psychosis (CHR) trials

Quick facts

Study typeInterventional
Ages12 Years to 25 Years
SexAll
Enrollment223 (estimated)
SponsorUniversity of California, Davis
Academic / other
Locations6 sites (Elk Grove, California and 5 other locations)
StatusRecruiting
StartedMarch 20, 2023
Main results expectedOctober 1, 2026
Study endsOctober 1, 2026
Registry record updatedDecember 15, 2025
Trial IDNCT06640803 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this program are youths aged 12-25 who are receiving care in designated community mental health clinics and are assessed to be at clinical high risk for psychosis.

Probably not a fit

Patients with intellectual disabilities or those requiring urgent clinical care at a higher level will not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This program evaluates a stepped-care intervention aimed at identifying and treating youths aged 12-25 who are at clinical high risk for psychosis in Sacramento, California. It involves universal screening in community mental health clinics and a team-based intervention that includes training in Cognitive Behavioral Case Management (CBCM). The initiative is designed to enhance the capacity of local clinics to manage these at-risk youths and triage them to specialized services when necessary. The program will be implemented across multiple community mental health centers, ensuring access for those with public insurance or no insurance.

Why it matters

Potential benefit: If successful, this program could significantly improve early identification and treatment of psychosis in at-risk youths, potentially preventing the onset of full-blown psychotic disorders.

How similar studies have gone: Other studies have shown success with stepped-care approaches in mental health, indicating potential for this program's effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Clinical High Risk for Psychosis Syndrome as assessed by the mini-SIPS
2. Aged between 12-25 years old
3. Receiving care in one of six identified community mental health clinics
4. Eligibility for Sacramento County Medicare
5. Ability to provide informed consent

Exclusion Criteria:

1. Intellectual disability (IQ\<70)
2. Urgent clinical need for a higher level of care

Where it's running

  • River Oak Center for Children
    Elk Grove, California, United States
    Recruiting
  • Turning Point Community Programs
    Elk Grove, California, United States
    Recruiting
  • University of California Department of Psychiatry and Behavioral Sciences; Early Psychosis Programs
    Sacramento, California, United States
    Recruiting
  • University of California-Davis CAARE Diagnostic and Treatment Center
    Sacramento, California, United States
    Recruiting
  • Capital Star Community Services
    Sacramento, California, United States
    Recruiting
  • Heartland Child and Family Services
    Sacramento, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.